EarLens Stock

earlens.comHealthcareFounded: 2005Funding to Date: $249.38MM

Earlens Corporation is a medical device company committed to providing hearing impaired patients with a state-of-art hearing solution that is designed to change the current standard of care for sound performance.

Register for Details

For more details on financing and valuation for EarLens, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for EarLens.

Register Today

Team

Management Team

George Harter Jr.
Chief Financial Officer
Leilani Latimer
Chief Marketing Officer
Rodney Perkins MD
Founder, Chief Medical Officer & Board Member
William Facteau
Chief Executive Officer, President & Board Member

Board Members

Henry Plain Jr.
Lightstone Ventures
Nael Kassar
KCK Group
Ryan Drant
New Enterprise Associates
Vincent Racano
William Facteau
Greg Garfield JD
KCK Group
Robert Croce
Steven Elms
Aisling Capital
Yoh-Chie Lu
Vertex Ventures HC
Frank Torti MD
New Enterprise Associates
Michael Favet
KCK Group
Rodney Perkins MD
Thomas Prescott
Arthur Taylor

Other companies like EarLens in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$885.01MM

News

/PRNewswire/ -- Earlens Corporation, a medical technology company that has created the world's first nonsurgical hearing solution that directly vibrates the...
/PRNewswire/ -- Earlens Corporation, Inc., a privately held medical technology company that created and commercialized a revolutionary hearing aid, today...
Earlens Corporation, Inc., a Menlo Park, CA-based medical technology company, closed $118M debt and equity financing. The deal included: – a $73m Series C financing led by Vertex Healthcare with participation from Cochlear Ltd, CRG, RK Mellon, Windham Venture Partners, Sightline Partners, New Enterprise Associates, Aisling Capital, Lightstone Ventures, and Medtronic, and – the establishment …